Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36951 - 36975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	DFNA5	1687	downregulated	entinostat results in decreased expression of DFNA5 mRNA	7p15.3	A21037
Entinostat	Investigational	DGKE	8526	upregulated	entinostat results in increased expression of DGKE mRNA	17q22	A21035
Entinostat	Investigational	DGKH	160851	upregulated	entinostat results in increased expression of DGKH mRNA	13q14.11	A21035
Entinostat	Investigational	DGKK	139189	upregulated	entinostat results in increased expression of DGKK mRNA	Xp11.22	A21037
Entinostat	Investigational	DHRS2	10202	upregulated	entinostat results in increased expression of DHRS2 mRNA	14q11.2	A21037
Entinostat	Investigational	DHRS3	9249	upregulated	entinostat results in increased expression of DHRS3 mRNA	1p36.21	A21037
Entinostat	Investigational	DHX30	22907	downregulated	entinostat results in decreased expression of DHX30 mRNA	3p21.31	A21035
Entinostat	Investigational	DHX58	79132	upregulated	entinostat results in increased expression of DHX58 mRNA	17q21.2	A21037
Entinostat	Investigational	DIAPH2	1730	upregulated	entinostat results in increased expression of DIAPH2 mRNA	Xq21.33	A21037
Entinostat	Investigational	DIDO1	11083	downregulated	entinostat results in decreased expression of DIDO1 mRNA	20q13.33	A21037
Entinostat	Investigational	DIO1	1733	downregulated	entinostat results in decreased expression of DIO1 mRNA	1p32.3	A21035
Entinostat	Investigational	DIO3	1735	downregulated	entinostat results in decreased expression of DIO3 mRNA	14q32.31	A21037
Entinostat	Investigational	DIRAS3	9077	upregulated	entinostat results in increased expression of DIRAS3 mRNA	1p31.3	A21035
Entinostat	Investigational	DIS3	22894	downregulated	entinostat results in decreased expression of DIS3 mRNA	13q21.33	A21037
Entinostat	Investigational	DISP1	84976	upregulated	entinostat results in increased expression of DISP1 mRNA	1q41	A21035
Entinostat	Investigational	DLG3	1741	downregulated	entinostat results in decreased expression of DLG3 mRNA	Xq13.1	A21035
Entinostat	Investigational	DLGAP1-AS1	649446	upregulated	entinostat results in increased expression of DLGAP1-AS1 mRNA	18p11.31	A21035
Entinostat	Investigational	DLGAP1-AS2	84777	upregulated	entinostat results in increased expression of DLGAP1-AS2 mRNA	18p11.31	A21037
Entinostat	Investigational	DLK1	8788	downregulated	entinostat results in decreased expression of DLK1 mRNA	14q32.2	A21037
Entinostat	Investigational	DLL1	28514	downregulated	entinostat results in decreased expression of DLL1 mRNA	6q27	A21037
Entinostat	Investigational	DLX4	1748	upregulated	entinostat results in increased expression of DLX4 mRNA	17q21.33	A21035
Entinostat	Investigational	DLX6	1750	downregulated	entinostat results in decreased expression of DLX6 mRNA	7q21.3	A21037
Entinostat	Investigational	DMC1	11144	upregulated	entinostat results in increased expression of DMC1 mRNA	22q13.1	A21035
Entinostat	Investigational	DMRT1	1761	upregulated	entinostat results in increased expression of DMRT1 mRNA	9p24.3	A21035
Entinostat	Investigational	DMRT3	58524	downregulated	entinostat results in decreased expression of DMRT3 mRNA	9p24.3	A21037

Displaying entries 36951 - 36975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability